L.B. Bohle Presents QbCon® 1 – The Future of Continuous Manufacturing at FCE Pharma 2025

Ennigerloh, Germany: – World-respected builder of advanced systems for pharma production, L.B. Bohle, will showcase its leadership in continuous manufacturing technology when it returns as an exhibitor to Latin America’s premier pharma and fine chemicals expo, Brazil’s annual FCE Pharma show in São Paulo.

L.B. Bohle will again exhibit under the banner of its regional agent, customized production project specialist Maquidrex Machinery and Equipment at Booth F51 at the Sāo Paulo Expo Center.

Unique continuous manufacturing solution

The centerpiece of the L.B. Bohle display stand will be its revolutionary QbCon® 1, the world’s first and only truly continuous wet granulator and dryer for research & development and small-scale applications.

QbCon® 1 is the only R&D system in the world that meets the quality requirements of pharmaceutical manufacturing. It provides an ideal entry route into continuous production as a standalone machine designed for R&D scale installations.

The machine provides truly continuous wet granulation and drying with no sub-batches, or blocked filters. It features very precise process control for improved product quality, also being designed and configured for increased flexibility and operator safety. The integrated  process analytics deliver shorter development cycles, along with seamless and controlled production, consuming fewer resources with greater efficiency for overall cost reduction in development.

A particular feature of the QbCon® 1 is short residence time of granules in the dryer. This is essential for removal of defective products without having to discard a large part of the batch and  also simplifies material traceability in the continuous process, making it easier to construct audit trail between raw materials and finished tablet.

Respected LATAM  presence

With a large installed machine base, L.B. Bohle is a well-known and respected process partner for  South America’s pharma manufacturers .

The L.B. Bohle team at FCE Pharma will include its Area Sales Manager for South America, Peter Pogoda. He will be present throughout the show to discuss current projects and provide information about its comprehensive product portfolio for pharmaceutical OSD production.

About L.B. Bohle

Founded in 1981, L.B. Bohle Maschinen und Verfahren GmbH (L.B. Bohle) has established a worldwide reputation as a producer and supplier of advanced systems for pharmaceutical manufacturing, based on a track record of technological innovation and continuous improvement.

Based at Ennigerloh in Northwest Germany, L.B. Bohle operates worldwide, offering advanced solutions for every aspect of oral solid dose (OSD) and nutraceutical tablet production, including weighing & dosing, grinding & sieving, blending, tablet coating,  handling systems, cleaning and containment, process monitoring and continuous manufacturing.

The company’s guiding vision is one of technological innovation in the production of pharmaceutical solids. This supports a core mission to deliver maximum product efficiency increases for its customers, through continuous development and product innovations that not only increase quality and efficiency but also strengthen competitive edge and sustainability.

To these ends, L.B. Bohle offers both complete production lines and solutions for individual production steps, focusing on rapid development and production of sophisticated, pragmatic, and customized applications.

The company operates development and manufacturing facilities at its home base at Ennigerloh and at Sassenberg, both in North Rhine-Westphalia. Additionally, it has sales and service subsidiaries in the USA (Warminster, PA) in India (headquarter in Ahmedabad and Innovation Centre in Hyderabad), and in Switzerland (Reiden). It is also represented by more than 40 qualified sales partners worldwide, having become a globally recognized brand.

Further information at: www.lbbohle.com or www.continuous-manufacturing.com or www.coating-tablets.com

About FCE Pharma 2025

Brazil’s annual FCE Pharma Expo has become the principal marketing, communications and sales platform for the South and Central American pharmaceutical and fine chemical engineering industries. FCE Pharma is unique in Latin America in bringing the biggest products and services suppliers from across the pharmaceutical industry production chain together under one roof and is a major driver of the pharma-based economy in the region.

Featuring four conference tracks, and a co-located trade exhibition, the 29th FCE Pharma Expo (FCE Brasil 2024) will again be a three-day event opening on June 10 at the São Paulo Expo center in  Brazil.

The 2024 event attracted some 21,500 visitors and more than 600 exhibitors, representing a host of pharmaceutical industry professionals connected with manufacture, supply and distribution of products and services including packaging, labeling, machines and equipment, quality and contamination control, transport and logistics, outsourcing and consultancy, laboratory and analytical equipment, process equipment, valves, sprays, industrial automation, technology and printing services.

The event is organized by Nürnberg Messe Brazil with more information at https://www.fcepharma.com.br

Resources

Click on FCE Pharma: from research to product to apply for free entry tickets for FCE Pharma 2025.
Click on Maquidrex Machinery and Equipment for stand information.
Click on Continuous granulation and drying with QbCon® 1 for further information.
Visit Bohle  Technology Center and Service Center virtually in a 360° tour.